Unique Platform
We believe that our proprietary continuous drug delivery technology could lead to NEW therapies with profound safety and efficacy benefits.
IP Portfolio
4 USPTO Patent Applications filed
4 PCT Patent Applications filed
1 Provisional Application filed
Experienced Team
Pike’s Management, Advisors, and Transdermal Lab, bring together decades of experience in Capital Markets, Pharma Development, IP Strategy, Transdermal Formulation, Regulatory Strategy and Clinical Trial Design and Management.
1 million
People living with Parkinson’s Disease in the U.S.
People living with Parkinson’s Disease in the U.S.
Parkinson’s Foundation
US$52bn
The estimated combined direct and indirect cost of Parkinson’s in the U.S.
The estimated combined direct and indirect cost of Parkinson’s in the U.S.
Parkinson’s Foundation
51.5m (20.6%)
US. adults that experienced mental illness in 2019
US. adults that experienced mental illness in 2019
NAMI National Alliance on Mental Illness
US$15bn
Estimated value of the U.S. Antidepressant market by 2025
Estimated value of the U.S. Antidepressant market by 2025
Brandessence Market Research